Anastrozole for prevention of breast cancer in high-risk postmenopausal women (IBIS-II): an international, double-blind, randomised placebo-controlled trial

[1]  M. Cowie.  National Institute for Health and Care Excellence. , 2015, European heart journal.

[2]  C. Zouboulis,et al.  Steroidogenesis in the skin: Implications for local immune functions , 2013, The Journal of Steroid Biochemistry and Molecular Biology.

[3]  J. Cuzick,et al.  Use of pharmacologic interventions for breast cancer risk reduction: American Society of Clinical Oncology clinical practice guideline. , 2013, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[4]  A. LaCroix,et al.  Selective oestrogen receptor modulators in prevention of breast cancer: an updated meta-analysis of individual participant data , 2013, The Lancet.

[5]  C. Rapuano,et al.  Dry eye syndrome in aromatase inhibitor users , 2012, Clinical & experimental ophthalmology.

[6]  R. Kay.  The Analysis of Survival Data , 2012 .

[7]  J. Manson,et al.  Conjugated equine oestrogen and breast cancer incidence and mortality in postmenopausal women with hysterectomy: extended follow-up of the Women's Health Initiative randomised placebo-controlled trial. , 2012, The Lancet. Oncology.

[8]  Jack Cuzick,et al.  A breast cancer prediction model incorporating familial and personal risk factors , 2012 .

[9]  S. Luoh,et al.  Breast Cancer Medications and Vision: Effects of Treatments for Early-stage Disease , 2011, Current eye research.

[10]  Karen A Gelmon,et al.  Exemestane for breast-cancer prevention in postmenopausal women. , 2011, The New England journal of medicine.

[11]  K. Pritchard,et al.  Aromatase inhibitor therapy: toxicities and management strategies in the treatment of postmenopausal women with hormone-sensitive early breast cancer , 2011, Breast Cancer Research and Treatment.

[12]  A. Jemal,et al.  Global Cancer Statistics , 2011 .

[13]  G. Kimmick.  Faculty Opinions recommendation of Effect of anastrozole and tamoxifen as adjuvant treatment for early-stage breast cancer: 10-year analysis of the ATAC trial. , 2010 .

[14]  Jack Cuzick,et al.  Effect of anastrozole and tamoxifen as adjuvant treatment for early-stage breast cancer: 10-year analysis of the ATAC trial. , 2010, The Lancet. Oncology.

[15]  J. Cuzick,et al.  Meta-analysis of breast cancer outcomes in adjuvant trials of aromatase inhibitors versus tamoxifen. , 2010, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[16]  J. Thigpen.  Aromatase Inhibitor–Induced Carpal Tunnel Syndrome: Results From the ATAC Trial , 2010 .

[17]  J. Cuzick,et al.  Aromatase inhibitor-induced carpal tunnel syndrome: results from the ATAC trial. , 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[18]  M. Laroche,et al.  Joint pain with aromatase inhibitors: abnormal frequency of Sjögren's syndrome. , 2007, The Journal of rheumatology.

[19]  J. Cuzick,et al.  Long-term results of tamoxifen prophylaxis for breast cancer--96-month follow-up of the randomized IBIS-I trial. , 2007, Journal of the National Cancer Institute.

[20]  J. Forbes,et al.  Five years of letrozole compared with tamoxifen as initial adjuvant therapy for postmenopausal women with endocrine-responsive early breast cancer: update of study BIG 1-98. , 2007, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[21]  N. Boyd,et al.  Mammographic density and the risk and detection of breast cancer. , 2007, The New England journal of medicine.

[22]  V. McCormack,et al.  Breast Density and Parenchymal Patterns as Markers of Breast Cancer Risk: A Meta-analysis , 2006, Cancer Epidemiology Biomarkers & Prevention.

[23]  Y Wang,et al.  Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials , 2005, The Lancet.

[24]  E. Campos,et al.  Menopause and dry eye. A possible relationship , 2005, Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology.

[25]  J. Cuzick.  Aromatase inhibitors for breast cancer prevention. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[26]  Stephen W Duffy,et al.  A breast cancer prediction model incorporating familial and personal risk factors , 2004, Hereditary Cancer in Clinical Practice.

[27]  M Baum,et al.  First results from the International Breast Cancer Intervention Study (IBIS-I): a randomised prevention trial , 2002, The Lancet.

[28]  J. Cuzick,et al.  Anastrozole alone or in combination with tamoxifen versus tamoxifen alone for adjuvant treatment of postmenopausal women with early breast cancer: first results of the ATAC randomised trial , 2002, The Lancet.

[29]  D. Wickerham,et al.  Findings from recent National Surgical Adjuvant Breast and Bowel Project adjuvant studies in stage I breast cancer. , 2001, Journal of the National Cancer Institute. Monographs.

[30]  I. Toda,et al.  Identification of androgen, estrogen and progesterone receptor mRNAs in the eye. , 2000, Acta ophthalmologica Scandinavica.

[31]  A. Jemal,et al.  Global cancer statistics , 2011, CA: a cancer journal for clinicians.

[32]  H. Johansson,et al.  Adjuvant tamoxifen therapy for early stage breast cancer and second primary malignancies. Stockholm Breast Cancer Study Group. , 1995, Journal of the National Cancer Institute.

[33]  M. Carcangiu.  Re: Endometrial cancer in tamoxifen-treated breast cancer patients: findings from the National Surgical Adjuvant Breast and Bowel Project (NSABP) B-14. , 1994, Journal of the National Cancer Institute.

[34]  C. Redmond,et al.  Endometrial cancer in tamoxifen-treated breast cancer patients: findings from the National Surgical Adjuvant Breast and Bowel Project (NSABP) B-14. , 1994, Journal of the National Cancer Institute.

[35]  D. English,et al.  Oestrogens and endometrial cancer: effect of other risk factors on the association. , 1980, Maturitas.

[36]  D. Cox.  Regression Models and Life-Tables , 1972 .

[37]  E. Kaplan,et al.  Nonparametric Estimation from Incomplete Observations , 1958 .

[38]  D.,et al.  Regression Models and Life-Tables , 2022 .